z-logo
open-access-imgOpen Access
Fatal 2009 pandemic influenza A (H1N1) in a bone marrow transplant recipient
Author(s) -
Anselmo Abdo Cuza,
Carlos Alfonso,
Guillermo Andrés Díaz Flórez,
Mario Wilford,
Maykel Rocha,
Niurka Verdecia
Publication year - 2010
Publication title -
the journal of infection in developing countries
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.322
H-Index - 49
eISSN - 2036-6590
pISSN - 1972-2680
DOI - 10.3855/jidc.1066
Subject(s) - medicine , ards , bone marrow transplant , immunosuppression , population , immunology , vaccination , pandemic , virus , bone marrow , virology , lung , covid-19 , bone marrow transplantation , disease , infectious disease (medical specialty) , environmental health
Conditions characterized by immunosuppression have been recently reported as risk factors for severe novel swine-origin influenza A (H1N1) virus (S-OIV) infection during the current 2009 pandemic.  We report clinical and virological findings, antiviral therapy, and post-mortem study of S-OIV in an adult bone marrow transplant recipient. The viral genome was amplified by real time reverse transcriptase polymerase chain reaction (RT-PCR) from a nasopharyngeal swab specimen. The patient developed acute respiratory distress syndrome, septic shock, and eventually succumbed with a severe pulmonary haemorrhage. To the best of our knowledge, the entire clinical/therapy management and pathological examination in a transplant recipient infected with the S-OIV has not been previously documented. The fatal ending in this bone marrow transplant recipient supports recommendations that call for education measures, S-OIV vaccination, early diagnosis and aggressive treatment in the transplant population.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom